Copyright
©2012 Baishideng Publishing Group Co.
World J Hepatol. Nov 27, 2012; 4(11): 291-298
Published online Nov 27, 2012. doi: 10.4254/wjh.v4.i11.291
Published online Nov 27, 2012. doi: 10.4254/wjh.v4.i11.291
Table 2 Univariate and multivariate logistic regression analyses of the various parameters in predicting in-hospital mortality
Parameter | Beta coefficient | Standard error | Odds ratios (95% CI) | P value |
Univariate logistic regression analysis | ||||
Age, yr | 0.02 | 0.00 | 1.02 (1.02-1.03) | < 0.001 |
Hepatoma | 0.95 | 0.07 | 2.57 (2.25-2.95) | < 0.001 |
Ascites | 1.47 | 0.07 | 4.36 (3.80-5.02) | < 0.001 |
Hepatic encephalopathy | 1.29 | 0.07 | 3.62 (3.13-4.19) | < 0.001 |
Cause of liver cirrhosis (reference group: NBNCNA) | ||||
Hepatitis C | -0.30 | 0.10 | 0.74 (0.61-0.91) | 0.004 |
Hepatitis B | -0.17 | 0.10 | 0.85 (0.70-1.03) | NS (0.098) |
Alcoholic | -0.76 | 0.11 | 0.47 (0.38-0.58) | < 0.001 |
Hepatitis C + hepatitis B | -0.51 | 0.22 | 0.60 (0.39-0.92) | 0.020 |
Hepatitis C + alcoholic | -0.53 | 0.17 | 0.59 (0.42-0.82) | 0.002 |
Hepatitis B + alcoholic | -0.15 | 0.36 | 0.86 (0.42-1.74) | NS (0.670) |
Hepatitis C + hepatitis B + alcoholic | -0.47 | 0.28 | 0.63 (0.36-1.09) | NS (0.098) |
Child–Pugh points | 0.67 | 0.02 | 1.95 (1.87-2.03) | < 0.001 |
MELD score | 0.22 | 0.01 | 1.25 (1.23-1.27) | < 0.001 |
BUN, mg/dL | 0.07 | 0.00 | 1.07 (1.06-1.07) | < 0.001 |
Creatinine, mg/dL | 0.72 | 0.03 | 2.05 (1.93-2.18) | < 0.001 |
eGFR, mL/(min∙1.73 m-2) (MDRD-4) | -0.04 | 0.00 | 0.97 (0.96-0.97) | < 0.001 |
eGFR, mL/(min∙1.73 m-2) (MDRD-6) | -0.05 | 0.00 | 0.95 (0.95-0.96) | < 0.001 |
eGFR, mL/(min∙1.73 m-2) (CKD-EPI) | -0.04 | 0.00 | 0.97 (0.96-0.96) | < 0.001 |
Albumin, g/dL | -1.97 | 0.07 | 0.14 (0.12-0.16) | < 0.001 |
Total bilirubin, mg/dL | 0.20 | 0.01 | 1.22 (1.20-1.25) | < 0.001 |
INR | 1.74 | 0.08 | 5.70 (4.87-6.67) | < 0.001 |
Multivariate logistic regression analysis | ||||
Age, yr | 0.03 | 0.01 | 1.03 (1.01-1.04) | < 0.001 |
Hepatoma | 0.95 | 0.13 | 2.60 (2.02-3.34) | < 0.001 |
Cause of liver cirrhosis (reference group: NBNCNA) | ||||
Hepatitis C | -0.19 | 0.18 | 0.83 (0.58-1.18) | NS (0.299) |
Hepatitis B | -0.28 | 0.19 | 0.76 (0.52-1.10) | NS (0.139) |
Alcoholic | -0.21 | 0.22 | 0.81 (0.52-1.25) | NS (0.342) |
Hepatitis C + hepatitis B | -1.03 | 0.40 | 0.36 (0.16-0.78) | 0.010 |
Hepatitis C + alcoholic | -0.79 | 0.35 | 0.46 (0.23-0.90) | 0.023 |
Hepatitis B + alcoholic | 0.32 | 0.57 | 1.38 (0.45-4.22) | NS (0.576) |
Hepatitis C + hepatitis B + alcoholic | 0.54 | 0.47 | 1.71 (0.68-4.29) | NS (0.354) |
MELD score | 0.14 | 0.03 | 1.14 (1.09-1.20) | < 0.001 |
BUN, mg/dL | 0.04 | 0.00 | 1.05 (1.04-1.05) | < 0.001 |
eGFR, mL/(min∙1.73 m-2) (MDRD-4) | 0.03 | 0.01 | 1.03 (1.02-1.04) | < 0.001 |
eGFR, mL/(min∙1.73 m-2) (MDRD-6) | -0.03 | 0.01 | 0.97 (0.95-0.99) | < 0.001 |
Albumin, g/dL | -1.24 | 0.13 | 0.29 (0.22-0.38) | < 0.001 |
INR | 0.24 | 0.10 | 1.27 (1.04-1.54) | 0.019 |
- Citation: Chen YW, Chang CW, Chang CW, Wang TE, Wu CJ, Chen HH. Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score? World J Hepatol 2012; 4(11): 291-298
- URL: https://www.wjgnet.com/1948-5182/full/v4/i11/291.htm
- DOI: https://dx.doi.org/10.4254/wjh.v4.i11.291